Tri Chemical Laboratories Income Statement

Financials in millions JPY. Fiscal year is February - January.

Millions JPY. Fiscal year is Feb - Jan.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Revenue	23,883	18,905	11,246	13,803	11,574
Revenue Growth (YoY)	26.33%	68.10%	-18.52%	19.26%	18.09%
Cost of Revenue	14,864	10,894	7,160	8,224	6,740
Gross Profit	9,019	8,011	4,086	5,579	4,834
Selling, General & Admin	3,117	2,031	1,410	1,439	1,305
Research & Development	-	660	665	569	486
Operating Expenses	3,117	2,755	2,138	2,074	1,858
Operating Income	5,902	5,256	1,948	3,505	2,976
Interest Expense	-34.41	-23	-23	-28	-31
Interest & Investment Income	12.84	2	1	-	-
Earnings From Equity Investments	1,278	1,309	1,036	2,409	1,936
Currency Exchange Gain (Loss)	-	-	330	-	300
Other Non Operating Income (Expenses)	-68.17	38	8	300	129
EBT Excluding Unusual Items	7,090	6,582	3,300	6,186	5,310
Gain (Loss) on Sale of Assets	-	-	-24	-	-16
Pretax Income	7,090	6,582	3,276	6,186	5,294
Income Tax Expense	1,575	1,621	806	1,354	1,199
Net Income	5,515	4,961	2,470	4,832	4,095
Net Income to Common	5,515	4,961	2,470	4,832	4,095
Net Income Growth	11.17%	100.85%	-48.88%	18.00%	21.26%
Shares Outstanding (Basic)	32	32	32	32	32
Shares Outstanding (Diluted)	32	32	32	32	32
Shares Change (YoY)	-	-	-	0.25%	3.74%
EPS (Basic)	169.72	152.66	76.01	148.69	126.33
EPS (Diluted)	169.72	152.66	76.01	148.69	126.33
EPS Growth	11.17%	100.85%	-48.88%	17.70%	16.89%
Free Cash Flow	-2,491	606	1,233	4,862	2,757
Free Cash Flow Per Share	-76.66	18.65	37.94	149.61	85.05
Dividend Per Share	35.000	35.000	30.000	30.000	20.000
Dividend Growth	-	16.67%	-	50.00%	17.65%
Gross Margin	37.76%	42.38%	36.33%	40.42%	41.77%
Operating Margin	24.71%	27.80%	17.32%	25.39%	25.71%
Profit Margin	23.09%	26.24%	21.96%	35.01%	35.38%
Free Cash Flow Margin	-10.43%	3.21%	10.96%	35.22%	23.82%
EBITDA	7,820	6,628	3,252	4,714	3,995
EBITDA Margin	32.74%	35.06%	28.92%	34.15%	34.52%
D&A For EBITDA	1,917	1,372	1,304	1,209	1,019
EBIT	5,902	5,256	1,948	3,505	2,976
EBIT Margin	24.71%	27.80%	17.32%	25.39%	25.71%
Effective Tax Rate	22.21%	24.63%	24.60%	21.89%	22.65%

Updated Jan 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.